• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Antidiabetics Drug Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 129 Pages
  • Report Code: 24LS-21612
  • Formate :   
Download FREE Report Sample Download PDF File

Antidiabetics Drug -MARKET ADVISORY SERVICES

Antidiabetics Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antidiabetics Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Antidiabetics Drug market is segmented into
Metformin (Biguanides)
Insulin Sensitization Agent (TZD Use)
Sulfonated Ideal Urea Class
Meglitinides
Alpha Glucosidase Inhibitors

Segment by Application, the Antidiabetics Drug market is segmented into
Hospital
Household

Regional and Country-level Analysis
The Antidiabetics Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antidiabetics Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Antidiabetics Drug Market Share Analysis
Antidiabetics Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antidiabetics Drug business, the date to enter into the Antidiabetics Drug market, Antidiabetics Drug product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Bayer
Boehringer Ingelheim
Eli-Lilly
Johnson & Johnson
Merck
Novartis
Novo Nordisk
Sanofi
1 Study Coverage
1.1 Antidiabetics Drug Product Introduction
1.2 Market Segments
1.3 Key Antidiabetics Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antidiabetics Drug Market Size Growth Rate by Type
1.4.2 Metformin (Biguanides)
1.4.3 Insulin Sensitization Agent (TZD Use)
1.4.4 Sulfonated Ideal Urea Class
1.4.5 Meglitinides
1.4.6 Alpha Glucosidase Inhibitors
1.5 Market by Application
1.5.1 Global Antidiabetics Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Household
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Antidiabetics Drug Market Size, Estimates and Forecasts
2.1.1 Global Antidiabetics Drug Revenue 2015-2026
2.1.2 Global Antidiabetics Drug Sales 2015-2026
2.2 Global Antidiabetics Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Antidiabetics Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Antidiabetics Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Antidiabetics Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Antidiabetics Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Antidiabetics Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Antidiabetics Drug Revenue Forecast by Region (2021-2026)

3 Global Antidiabetics Drug Competitor Landscape by Players
3.1 Global Top Antidiabetics Drug Sales by Manufacturers
3.1.1 Global Antidiabetics Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Antidiabetics Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Antidiabetics Drug Manufacturers by Revenue
3.2.1 Global Antidiabetics Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Antidiabetics Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antidiabetics Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antidiabetics Drug Revenue in 2019
3.2.5 Global Antidiabetics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antidiabetics Drug Price by Manufacturers
3.4 Global Antidiabetics Drug Manufacturing Base Distribution, Product Types
3.4.1 Antidiabetics Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidiabetics Drug Product Type
3.4.3 Date of International Manufacturers Enter into Antidiabetics Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Antidiabetics Drug Market Size by Type (2015-2020)
4.1.1 Global Antidiabetics Drug Sales by Type (2015-2020)
4.1.2 Global Antidiabetics Drug Revenue by Type (2015-2020)
4.1.3 Antidiabetics Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antidiabetics Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Antidiabetics Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Antidiabetics Drug Revenue Forecast by Type (2021-2026)
4.2.3 Antidiabetics Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antidiabetics Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Antidiabetics Drug Market Size by Application (2015-2020)
5.1.1 Global Antidiabetics Drug Sales by Application (2015-2020)
5.1.2 Global Antidiabetics Drug Revenue by Application (2015-2020)
5.1.3 Antidiabetics Drug Price by Application (2015-2020)
5.2 Antidiabetics Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Antidiabetics Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Antidiabetics Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Antidiabetics Drug Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Antidiabetics Drug Market Size YoY Growth 2015-2026
6.1.1 China Antidiabetics Drug Sales YoY Growth 2015-2026
6.1.2 China Antidiabetics Drug Revenue YoY Growth 2015-2026
6.1.3 China Antidiabetics Drug Market Share in Global Market 2015-2026
6.2 China Antidiabetics Drug Market Size by Players (International and Local Players)
6.2.1 China Top Antidiabetics Drug Players by Sales (2015-2020)
6.2.2 China Top Antidiabetics Drug Players by Revenue (2015-2020)
6.3 China Antidiabetics Drug Historic Market Review by Type (2015-2020)
6.3.1 China Antidiabetics Drug Sales Market Share by Type (2015-2020)
6.3.2 China Antidiabetics Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Antidiabetics Drug Price by Type (2015-2020)
6.4 China Antidiabetics Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Antidiabetics Drug Sales Forecast by Type (2021-2026)
6.4.2 China Antidiabetics Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Antidiabetics Drug Price Forecast by Type (2021-2026)
6.5 China Antidiabetics Drug Historic Market Review by Application (2015-2020)
6.5.1 China Antidiabetics Drug Sales Market Share by Application (2015-2020)
6.5.2 China Antidiabetics Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Antidiabetics Drug Price by Application (2015-2020)
6.6 China Antidiabetics Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Antidiabetics Drug Sales Forecast by Application (2021-2026)
6.6.2 China Antidiabetics Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Antidiabetics Drug Price Forecast by Application (2021-2026)

7 North America
7.1 North America Antidiabetics Drug Market Size YoY Growth 2015-2026
7.2 North America Antidiabetics Drug Market Facts & Figures by Country
7.2.1 North America Antidiabetics Drug Sales by Country (2015-2020)
7.2.2 North America Antidiabetics Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Antidiabetics Drug Market Size YoY Growth 2015-2026
8.2 Europe Antidiabetics Drug Market Facts & Figures by Country
8.2.1 Europe Antidiabetics Drug Sales by Country
8.2.2 Europe Antidiabetics Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Antidiabetics Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Antidiabetics Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Antidiabetics Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Antidiabetics Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Antidiabetics Drug Market Size YoY Growth 2015-2026
10.2 Latin America Antidiabetics Drug Market Facts & Figures by Country
10.2.1 Latin America Antidiabetics Drug Sales by Country
10.2.2 Latin America Antidiabetics Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Antidiabetics Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Antidiabetics Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Antidiabetics Drug Sales by Country
11.2.2 Middle East and Africa Antidiabetics Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Antidiabetics Drug Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Description and Business Overview
12.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Antidiabetics Drug Products Offered
12.2.5 Bayer Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Antidiabetics Drug Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Eli-Lilly
12.4.1 Eli-Lilly Corporation Information
12.4.2 Eli-Lilly Description and Business Overview
12.4.3 Eli-Lilly Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli-Lilly Antidiabetics Drug Products Offered
12.4.5 Eli-Lilly Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Antidiabetics Drug Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Description and Business Overview
12.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Antidiabetics Drug Products Offered
12.6.5 Merck Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Description and Business Overview
12.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Antidiabetics Drug Products Offered
12.7.5 Novartis Recent Development
12.8 Novo Nordisk
12.8.1 Novo Nordisk Corporation Information
12.8.2 Novo Nordisk Description and Business Overview
12.8.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novo Nordisk Antidiabetics Drug Products Offered
12.8.5 Novo Nordisk Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Antidiabetics Drug Products Offered
12.9.5 Sanofi Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Antidiabetics Drug Products Offered
12.11.5 AstraZeneca Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antidiabetics Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidiabetics Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Antidiabetics Drug Market Segments

Table 2. Ranking of Global Top Antidiabetics Drug Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Antidiabetics Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Metformin (Biguanides)

Table 5. Major Manufacturers of Insulin Sensitization Agent (TZD Use)

Table 6. Major Manufacturers of Sulfonated Ideal Urea Class

Table 7. Major Manufacturers of Meglitinides

Table 8. Major Manufacturers of Alpha Glucosidase Inhibitors

Table 9. Global Antidiabetics Drug Market Size Growth Rate by Application 2020-2026 (K Units)

Table 10. Global Antidiabetics Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 11. Global Antidiabetics Drug Sales by Regions 2015-2020 (K Units)

Table 12. Global Antidiabetics Drug Sales Market Share by Regions (2015-2020)

Table 13. Global Antidiabetics Drug Revenue by Regions 2015-2020 (US$ Million)

Table 14. Global Antidiabetics Drug Sales Forecast by Region (2021-2026) (K Units)

Table 15. Global Antidiabetics Drug Sales by Manufacturers (2015-2020) (K Units)

Table 16. Global Antidiabetics Drug Sales Share by Manufacturers (2015-2020)

Table 17. Global Antidiabetics Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 18. Global Antidiabetics Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetics Drug as of 2019)

Table 19. Antidiabetics Drug Revenue by Manufacturers (2015-2020) (US$ Million)

Table 20. Antidiabetics Drug Revenue Share by Manufacturers (2015-2020)

Table 21. Key Manufacturers Antidiabetics Drug Price (2015-2020) (USD/Unit)

Table 22. Antidiabetics Drug Manufacturers Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Antidiabetics Drug Product Type

Table 24. Date of International Manufacturers Enter into Antidiabetics Drug Market

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Global Antidiabetics Drug Sales by Type (2015-2020) (K Units)

Table 27. Global Antidiabetics Drug Sales Share by Type (2015-2020)

Table 28. Global Antidiabetics Drug Revenue by Type (2015-2020) (US$ Million)

Table 29. Global Antidiabetics Drug Revenue Share by Type (2015-2020)

Table 30. Antidiabetics Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 31. Global Antidiabetics Drug Sales Share by Type (2021-2026)

Table 32. Global Antidiabetics Drug Sales by Application (2015-2020) (K Units)

Table 33. Global Antidiabetics Drug Sales Share by Application (2015-2020)

Table 34. Global Antidiabetics Drug Sales Share by Application (2021-2026)

Table 35. Global Antidiabetics Drug Sales Market Share Forecast by Application (2021-2026)

Table 36. Global Antidiabetics Drug Revenue by Application (2015-2020) (US$ Million)

Table 37. Global Antidiabetics Drug Revenue Market Share Forecast by Application (2021-2026)

Table 38. China Antidiabetics Drug Sales (K Units) of Key Companies (2015-2020)

Table 39. China Antidiabetics Drug Sales Share by Company (2015-2020)

Table 40. China Antidiabetics Drug Revenue (US$ Million) by Company (2015-2020)

Table 41. China Antidiabetics Drug Sales (K Units) by Type (2015-2020)

Table 42. China Antidiabetics Drug Sales Share by Type (2015-2020)

Table 43. China Antidiabetics Drug Revenue (US$ Million) Market Share by Type (2015-2020)

Table 44. China Antidiabetics Drug Price (K Units) by Type (2015-2020)

Table 45. China Antidiabetics Drug Sales (K Units) by Type (2021-2026)

Table 46. China Antidiabetics Drug Sales Share by Type (2021-2026)

Table 47. China Antidiabetics Drug Revenue (US$ Million) Market Share by Type (2021-2026)

Table 48. China Antidiabetics Drug Revenue Share by Type (2021-2026)

Table 49. China Antidiabetics Drug Price (K Units) by Type (2021-2026)

Table 50. China Antidiabetics Drug Sales (K Units) by Application (2015-2020)

Table 51. China Antidiabetics Drug Sales Share by Application (2015-2020)

Table 52. China Antidiabetics Drug Revenue (US$ Million) Market Share by Application (2015-2020)

Table 53. China Antidiabetics Drug Sales (K Units) by Application (2021-2026)

Table 54. China Antidiabetics Drug Sales Share by Application (2021-2026)

Table 55. China Antidiabetics Drug Revenue (US$ Million) Market Share by Application (2021-2026)

Table 56. China Antidiabetics Drug Revenue Share by Application (2021-2026)

Table 57. North America Antidiabetics Drug Sales by Country (2015-2020) (K Units)

Table 58. North America Antidiabetics Drug Sales Market Share by Country (2015-2020)

Table 59. North America Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)

Table 60. North America Antidiabetics Drug Revenue Market Share by Country (2015-2020)

Table 61. Europe Antidiabetics Drug Sales by Country (2015-2020) (K Units)

Table 62. Europe Antidiabetics Drug Sales Market Share by Country (2015-2020)

Table 63. Europe Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)

Table 64. Europe Antidiabetics Drug Revenue Market Share by Country (2015-2020)

Table 65. Asia Pacific Antidiabetics Drug Sales by Region (2015-2020) (K Units)

Table 66. Asia Pacific Antidiabetics Drug Sales Market Share by Region (2015-2020)

Table 67. Asia Pacific Antidiabetics Drug Revenue by Region (2015-2020) (US$ Million)

Table 68. Asia Pacific Antidiabetics Drug Revenue Market Share by Region (2015-2020)

Table 69. Latin America Antidiabetics Drug Sales by Country (2015-2020) (K Units)

Table 70. Latin America Antidiabetics Drug Sales Market Share by Country (2015-2020)

Table 71. Latin Americaa Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)

Table 72. Latin America Antidiabetics Drug Revenue Market Share by Country (2015-2020)

Table 73. Middle East and Africa Antidiabetics Drug Sales by Country (2015-2020) (K Units)

Table 74. Middle East and Africa Antidiabetics Drug Sales Market Share by Country (2015-2020)

Table 75. Middle East and Africa Antidiabetics Drug Revenue by Country (2015-2020) (US$ Million)

Table 76. Middle East and Africa Antidiabetics Drug Revenue Market Share by Country (2015-2020)

Table 77. AstraZeneca Corporation Information

Table 78. AstraZeneca Description and Business Overview

Table 79. AstraZeneca Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 80. AstraZeneca Antidiabetics Drug Product

Table 81. AstraZeneca Recent Development

Table 82. Bayer Corporation Information

Table 83. Bayer Description and Business Overview

Table 84. Bayer Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 85. Bayer Product

Table 86. Bayer Recent Development

Table 87. Boehringer Ingelheim Corporation Information

Table 88. Boehringer Ingelheim Description and Business Overview

Table 89. Boehringer Ingelheim Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 90. Boehringer Ingelheim Product

Table 91. Boehringer Ingelheim Recent Development

Table 92. Eli-Lilly Corporation Information

Table 93. Eli-Lilly Description and Business Overview

Table 94. Eli-Lilly Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 95. Eli-Lilly Product

Table 96. Eli-Lilly Recent Development

Table 97. Johnson & Johnson Corporation Information

Table 98. Johnson & Johnson Description and Business Overview

Table 99. Johnson & Johnson Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 100. Johnson & Johnson Product

Table 101. Johnson & Johnson Recent Development

Table 102. Merck Corporation Information

Table 103. Merck Description and Business Overview

Table 104. Merck Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 105. Merck Product

Table 106. Merck Recent Development

Table 107. Novartis Corporation Information

Table 108. Novartis Description and Business Overview

Table 109. Novartis Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 110. Novartis Product

Table 111. Novartis Recent Development

Table 112. Novo Nordisk Corporation Information

Table 113. Novo Nordisk Description and Business Overview

Table 114. Novo Nordisk Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 115. Novo Nordisk Product

Table 116. Novo Nordisk Recent Development

Table 117. Sanofi Corporation Information

Table 118. Sanofi Description and Business Overview

Table 119. Sanofi Antidiabetics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 120. Sanofi Product

Table 121. Sanofi Recent Development

Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 123. Key Challenges

Table 124. Market Risks

Table 125. Main Points Interviewed from Key Antidiabetics Drug Players

Table 126. Antidiabetics Drug Customers List

Table 127. Antidiabetics Drug Distributors List

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Antidiabetics Drug Product Picture

Figure 2. Global Antidiabetics Drug Sales Market Share by Type in 2020 & 2026

Figure 3. Metformin (Biguanides) Product Picture

Figure 4. Insulin Sensitization Agent (TZD Use) Product Picture

Figure 5. Sulfonated Ideal Urea Class Product Picture

Figure 6. Meglitinides Product Picture

Figure 7. Alpha Glucosidase Inhibitors Product Picture

Figure 8. Global Antidiabetics Drug Sales Market Share by Application in 2020 & 2026

Figure 9. Hospital

Figure 10. Household

Figure 11. Antidiabetics Drug Report Years Considered

Figure 12. Global Antidiabetics Drug Market Size 2015-2026 (US$ Million)

Figure 13. Global Antidiabetics Drug Sales 2015-2026 (K Units)

Figure 14. Global Antidiabetics Drug Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Antidiabetics Drug Sales Market Share by Region (2015-2020)

Figure 16. Global Antidiabetics Drug Sales Market Share by Region in 2019

Figure 17. Global Antidiabetics Drug Revenue Market Share by Region (2015-2020)

Figure 18. Global Antidiabetics Drug Revenue Market Share by Region in 2019

Figure 19. Global Antidiabetics Drug Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Antidiabetics Drug Revenue in 2019

Figure 21. Antidiabetics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Antidiabetics Drug Sales Market Share by Type (2015-2020)

Figure 23. Global Antidiabetics Drug Sales Market Share by Type in 2019

Figure 24. Global Antidiabetics Drug Revenue Market Share by Type (2015-2020)

Figure 25. Global Antidiabetics Drug Revenue Market Share by Type in 2019

Figure 26. Global Antidiabetics Drug Market Share by Price Range (2015-2020)

Figure 27. Global Antidiabetics Drug Sales Market Share by Application (2015-2020)

Figure 28. Global Antidiabetics Drug Sales Market Share by Application in 2019

Figure 29. Global Antidiabetics Drug Revenue Market Share by Application (2015-2020)

Figure 30. Global Antidiabetics Drug Revenue Market Share by Application in 2019

Figure 31. China Antidiabetics Drug Sales Growth Rate 2015-2026 (K Units)

Figure 32. China Antidiabetics Drug Revenue Growth Rate 2015-2026 (US$ Million)

Figure 33. China Antidiabetics Drug Market Share in Global Market 2015-2026

Figure 34. China 5 and 10 Largest Antidiabetics Drug Players Market Share by Revenue in Antidiabetics Drug in 2019

Figure 35. China Antidiabetics Drug Revenue Share by Type (2015-2020)

Figure 36. China Antidiabetics Drug Revenue Growth Rate by Type in 2015 & 2019

Figure 37. China Antidiabetics Drug Revenue Share by Application (2015-2020)

Figure 38. China Antidiabetics Drug Revenue Growth Rate by Application in 2015 & 2019

Figure 39. North America Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)

Figure 40. North America Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 41. North America Antidiabetics Drug Sales Market Share by Country in 2019

Figure 42. North America Antidiabetics Drug Revenue Market Share by Country in 2019

Figure 43. U.S. Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 44. U.S. Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Canada Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 46. Canada Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. Europe Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)

Figure 48. Europe Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 49. Europe Antidiabetics Drug Sales Market Share by Country in 2019

Figure 50. Europe Antidiabetics Drug Revenue Market Share by Country in 2019

Figure 51. Germany Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 52. Germany Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. France Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 54. France Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. U.K. Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 56. U.K. Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Italy Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 58. Italy Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Russia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 60. Russia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Asia Pacific Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)

Figure 62. Asia Pacific Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 63. Asia Pacific Antidiabetics Drug Sales Market Share by Region in 2019

Figure 64. Asia Pacific Antidiabetics Drug Revenue Market Share by Region in 2019

Figure 65. China Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 66. China Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Japan Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 68. Japan Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. South Korea Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 70. South Korea Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. India Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 72. India Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Australia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 74. Australia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Taiwan Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 76. Taiwan Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Indonesia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 78. Indonesia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Thailand Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 80. Thailand Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Malaysia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 82. Malaysia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Philippines Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 84. Philippines Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Vietnam Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 86. Vietnam Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Latin America Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)

Figure 88. Latin America Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 89. Latin America Antidiabetics Drug Sales Market Share by Country in 2019

Figure 90. Latin America Antidiabetics Drug Revenue Market Share by Country in 2019

Figure 91. Mexico Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 92. Mexico Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Brazil Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 94. Brazil Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Argentina Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 96. Argentina Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Middle East and Africa Antidiabetics Drug Sales Growth Rate 2015-2020 (K Units)

Figure 98. Middle East and Africa Antidiabetics Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Antidiabetics Drug Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Antidiabetics Drug Revenue Market Share by Country in 2019

Figure 101. Turkey Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 102. Turkey Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 104. Saudi Arabia Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Antidiabetics Drug Sales Growth Rate (2015-2020) (K Units)

Figure 106. U.A.E Antidiabetics Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Porter's Five Forces Analysis

Figure 108. Antidiabetics Drug Value Chain

Figure 109. Channels of Distribution

Figure 110. Distributors Profiles

Figure 111. Bottom-up and Top-down Approaches for This Report

Figure 112. Data Triangulation

Figure 113. Key Executives Interviewed

AstraZeneca

Bayer

Boehringer Ingelheim

Eli-Lilly

Johnson & Johnson

Merck

Novartis

Novo Nordisk

Sanofi

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3081

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase